• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CADD® ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CADD® ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7091-24
Medical Device Problem Code Infusion or Flow Problem (2964)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/01/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was reported that the event occurred some time between (b)(6) 2017.The exact date is unknown.Customer has not returned the device to the manufacturer for device evaluation.If the device becomes available and is returned and evaluated, the manufacturer will file a follow-up report detailing the results of the evaluation.
 
Event or Problem Description
It was reported that before changing the perfusion bag, air bubbles were present in the tubing of a cadd® administration set.The fault was noticed when the pump alarmed and displayed the message: "air bubbles in tube".The tubing was purged, but the bubbles then appeared in the cassette.No injury was reported.
 
Additional Manufacturer Narrative
One smiths medical cadd® administration set was returned for analysis without original packaging.No abnormality was detected upon visual inspection of device.Functional testing was performed by infusing water through the set and connected to a cadd solis pump; no problems identified by priming the tubing and by running the pump.A sample of 32 units were taken for visual inspection to verify for any damages, workmanship defect and solvent bonds; finding no discrepancies.Accuracy testing was performed on four samples using balance melted toledo; no discrepancies found.Root cause cannot be determined since the complaint was not confirmed due to the fact that the sample was tested and no difficulty priming tubing and no air was detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD® ADMINISTRATION SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
MDR Report Key6711876
Report Number3012307300-2017-01470
Device Sequence Number221127
Product Code FPA
UDI-Device Identifier10610586024160
UDI-Public10610586024160
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K000942
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other,user facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Expiration Date07/28/2021
Device Catalogue Number21-7091-24
Device Lot Number46X555
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/02/2017
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/26/2017
Supplement Date Received by Manufacturer04/25/2018
Initial Report FDA Received Date07/13/2017
Supplement Report FDA Received Date05/23/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-